Doctor Evidence Conducted Systematic Evidence Review for Leading Cardiology Societies for Bradycardia Guideline Evidence Review and Analyses
SANTA MONICA, Calif., Nov. 6, 2018 /PRNewswire/ -- Today, the American College of Cardiology (ACC), American Heart Association (AHA), and Heart Rhythm Society (HRS) published guidelines on the diagnosis and treatment of bradycardia, an abnormally slow heart rate, along with the supporting systematic review. The 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay were simultaneously published in Circulation, the Journal of the American College of Cardiology (JACC), and HeartRhythm. An Executive Summary was also published in all three journals: Circulation, JACC, and HeartRhythm.
Connecting Published Data To Real World Evidence: What's The DIF (Data Impact Factor)
SANTA MONICA, Calif., Nov. 5, 2018 /PRNewswire/ -- Doctor Evidence has launched DIF—the Data Impact Factor—technology for identifying data cohorts, across time and various reported data sets. As technology progresses, it has become possible to move from past paradigms, like the Journal Impact Factor, which is an index of the relative influence of leading journals. Today's innovative technologies can assign actual weights, prominence, and influence factors to individual data cohorts across all research or within a selected topic area. DIF embraces the increased capabilities for micro-tagging of clinical trial research and subsequent representations of that data.
American Thoracic Society publishes guideline on malignant pleural effusions; Doctor Evidence collaborated on the underlying meta-analysis
New Guideline Recommends Minimally Invasive Ways of Treating Malignant Pleural Effusions
Oct. 1, 2018─A new guideline to help clinicians manage malignant pleural effusions (MPEs) has been developed by the American Thoracic Society, the Society of Thoracic Surgeons and the Society of Thoracic Radiology. The clinical practice guideline is published online in the Oct. 1 American Journal of Respiratory and Critical Care Medicine.
Doctor Evidence collaborated on the underlying systematic review for new guideline published by leading oncology association
Guideline addresses the management of side effects from immune checkpoint inhibitors treatments
SANTA MONICA, Calif., Feb. 14, 2018 /PRNewswire/ -- Doctor Evidence (DRE), a global health technology and data company, is proud to have performed the systematic review of evidence, through the GROWTH program, in support of a new guideline issued by the American Society of Clinical Oncology, Inc. (ASCO®), the world's leading professional organization representing physicians who care for people with cancer, in collaboration with the National Comprehensive Cancer Network® (NCCN®). The organizations collaborated to develop comprehensive guidelines to help clinicians with optimal strategies for the identification and diagnosis of adverse events associated with immune checkpoint inhibitors and to offer guidance on their safe management.
Doctor Evidence proud to contribute to the systematic review for the 2017 hypertension guidelines
Journal of the American College of Cardiology November 2017
Just Accepted - Systematic Review for 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Authors: David M. Reboussin, Norrina B. Allen, Michael E. Griswold, Eliseo Guallar, Yuling Hong, Daniel T. Lackland, Edgar (Pete) R. Miller III, Tamar Polonsky, Angela M. Thompson-Paul and Suma Vupputuri
Doctor Evidence Subscription Software Platform For ASCO Meeting Abstracts
September 18th, 2017
SANTA MONICA, Calif., Sept. 18, 2017 /PRNewswire/ -- Doctor Evidence (DRE), a global health technology and consulting company, has signed a contract with the American Society of Clinical Oncology, Inc. (ASCO®), the world's leading professional organization representing physicians who care for people with cancer, to digitize and host ASCO meeting abstracts in DRE's technology platform. This platform will be used for in-depth queries by researchers across abstracts with the capability to track data and changing research focus in the field of oncology over time. The product will be a subscription offering including new meeting abstracts as they become publicly available. Archived years of ASCO abstracts will also be available in the subscription offering.
DOCTOR EVIDENCE SUPPORTS ACC/AHA GUIDELINES EVIDENCE REVIEWS
April 25th, 2017
SANTA MONICA, Calif., April 25, 2017 /PRNewswire/ -- The American College of Cardiology and the American Heart Association ("ACC/AHA") published guidelines on lower extremity peripheral artery disease and syncope, along with the supporting systematic review on syncope. These jointly developed guidelines were simultaneously published in both Circulation and the Journal of the American College of Cardiology (JACC). Doctor Evidence, a software and services technology company that finds, categorizes and synthesizes data from published sources, assisted in the process.
DOCTOR EVIDENCE LAUNCHES GROWTH RESEARCH
October 13th, 2016
SANTA MONICA, Calif., Oct. 13, 2016 /PRNewswire/ -- Doctor Evidence (DRE) announces the launch of GROWTH Research, a new initiative to connect patient-level data to peer-reviewed data for clinical and policy decisions applicable at institutional, national, or global levels. GROWTH Research enables organizations to use the syntheses and analytic results of publicly validated data from the peer-reviewed literature to mine and investigate patient-level data for research and discovery purposes.
DOCTOR EVIDENCE PROVIDES GRANT FOR UNIVERSITY OF SOUTHERN CALIFORNIA’S DIGITAL FELLOW ON ADVANCING DIGITAL HEALTH SOLUTIONS
June 10th, 2016
SANTA MONICA, Calif., June 9, 2016 /PRNewswire/ -- Doctor Evidence, a leading evidence-based medicine company, announced today it will provide a grant to the University of Southern California (USC) Center for Body Computing (CBC) for the nation's first Digital Health Fellowship in the U.S. The 1-year Fellowship is a first of its kind digital health research and clinical training program developed at the CBC. Dr. Andrew Keibel, who is a recent graduate of the Keck Medicine of USC's Internal Medicine Residency Program, was chosen as the first Fellow. He will work on the CBC's innovative...
NATION’S FIRST DIGITAL HEALTH FELLOWSHIP CREATED AT USC CENTER FOR BODY COMPUTING NATION’S FIRST DIGITAL HEALTH FELLOWSHIP CREATED AT USC CENTER FOR BODY COMPUTING
June 9th, 2016
LOS ANGELES – Taking the next step as a national thought leader in digital health innovation among university-based medical centers, the University of Southern California (USC) Center for Body Computing (CBC) announced the first Digital Health Fellowship in the U.S. The inaugural 12-month Fellowship will provide exposure, training and research opportunities in digital health patient education, diagnosis and therapy that are under development and study at the USC CBC, the digital health technologies incubator of Keck Medicine of USC. The first Fellow, Andrew Keibel, MD, a recent graduate of the...
DOCTOR EVIDENCE LAUNCHES SITE TO TEST AND REPRODUCE SYSTEMATIC EVIDENCE REVIEWS
May 27th, 2016
SANTA MONICA, Calif., May 26, 2016 /PRNewswire/ -- Today Doctor Evidence launches GROWTH Replicator, a site that provides stakeholders across the healthcare ecosystem free access to a platform for the replication of systematic evidence reviews. Doctor Evidence (DRE) is a leading human-enabled technology and services company that provides solutions for dynamic identification, synthesis, and analysis of clinical information to perform evidence-based medicine evaluations. DRE's GROWTH Replicator enables users to utilize Doctor Evidence's proprietary Digital Outcome Conversion (DOC) technology to...
VALUE BASED CARE REACHING NEW HEIGHTS:
May 20th, 2016
SANTA MONICA, Calif., May 20, 2016 /PRNewswire/ -- Doctor Evidence, a global medical evidence software and services company, announced this week that the company will be working with CVS Health to help support evidence gathering for the formulary decision-making process. As part of an ongoing effort to provide the greatest value to its clients and their members, CVS Health has identified Doctor Evidence as an organization whose adherence to the highest methodological criteria will bring increased agility to its formulary process.
THE NEXT LEVEL OF ON-DEMAND EXPERT MEDICAL CARE IS HERE:
January 27th, 2016
LOS ANGELES – The University of Southern California (USC) Center for Body Computing (CBC), the digital health innovation accelerator for the Keck Medicine of USC medical enterprise, today announced its eight foundational partners for its Virtual Care Clinic (VCC). The disruptive digital health care model does not require patient or care providers to be present in the same place for seamless, integrated solutions designed to provide on-demand access to care. The VCC extends Keck Medicine of USC experts to anyone with a smartphone by harnessing cutting-edge technologies and creative solutions...
ALLTRIALS.NET: DOCTOR EVIDENCE JOINS 622 OTHER ORGANIZATIONS TO SIGN THE ALLTRIALS PETITION
November 3rd, 2015
Doctor Evidence is committed to advancing knowledge acceleration using all relevant evidence. We support the AllTrials campaign because it is an important step to ensure that patients and healthcare professionals make decisions based on trustworthy evidence.
LA BUSINESS JOURNAL: MEDICAL DATA BUSINESS CHECKS IN TO APP MARKET
November 2nd, 2015
HEALTH CARE: Prognosis for consumer service looks good to Doctor Evidence. By MARNI USHEROFF Staff Reporter Say you were diagnosed with prostate cancer and had to choose between chemotherapy or surgery. Though your doctor inundated you with information during your office visit, you can hardly remember anything and have many more questions.
DOCTOR EVIDENCE BRINGS VALUABLE HEALTH DATA TO IBM WATSON ECOSYSTEM
May 28, 2015
Today, Doctor Evidence, a clinical health research data provider, announced a content partnership with IBM Watson to contribute valuable clinical cancer research content to Watson’s oncology solutions and developer ecosystem. The partnership is part of IBM’s work to help the medical community advance patient-centered care through its new Watson Health unit. To date, IBM’s Watson for Oncology solution has ingested nearly 15 million pages of medical content, including over 200 medical textbooks and 300 medical journals. Doctor Evidence brings more than a decade...
DOCTOR EVIDENCE ANNOUNCES APPOINTMENT OF GLOBAL HEAD OF METHODOLOGY, INNOVATION & QUALITY, CRAIG WHITTINGTON, PHD
March 16th, 2015
Doctor Evidence, LLC is pleased to welcome Dr. Craig Whittington, PhD, to lead methodology services. Doctor Evidence clients will benefit from the growing set of services available to support their work in evidence-based medicine (EBM), especially the high level scientific and procedural expertise that will be provided by the new Global Head of Methodology, Innovation & Quality, Craig Whittington, PhD. Dr. Whittington most recently served as Associate Director (Clinical Effectiveness) of the National Collaborating Centre for Mental Health (NCCMH) and was a Senior Research Fellow at University of ...
DOCTOR EVIDENCE PARTNERING WITH HEALTHCARE DECISION-MAKERS ON HEPATITIS C EVIDENCE
July 30th, 2014
Doctor Evidence, LLC has developed a comprehensive database of clinical evidence in Hepatitis C (HCV) to address the evolving needs of healthcare stakeholders. Santa Monica, CA (PRWEB) July 29, 2014 Doctor Evidence (“DRE”), the Santa Monica, California-based healthcare information leader has responded to marketplace clamor related to the transformative innovations in Hepatitis C virus (HCV) treatments with a comprehensive comparative effectiveness database that allows healthcare decision-makers to quickly identify and synthesize available evidence in this evolving market. The DRE HCV Data Hub–...
ELSEVIER EVIDENCE-BASED MEDICINE CENTER SELECTS DOCTOR EVIDENCE FOR DIGITAL CLINICAL EVIDENCE PLATFORM
July 23rd, 2014
Doctor Evidence to provide a comprehensive clinical evidence platform to support Elsevier Clinical Solutions' global clinical product suite Philadelphia, PA, July 23, 2014 Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today that Elsevier Clinical Solutions' Evidence-based Medicine Center (EBM Center) has reached an agreement with Doctor Evidence LLC (DRE) to provide the platform engine supporting the Clinical Solutions' suite of evidence-based clinical solutions. "Doctor Evidence is tremendously excited to be working with ...
DOCTOR EVIDENCE TO BE PLATINUM SPONSOR OF THE GUIDELINES INTERNATIONAL NETWORK CONFERENCE IN AUSTRALIA THIS YEAR
June 17th, 2014
The conference theme, “Creation and Innovation: Guidelines in the Digital Age” parallels the objectives of Doctor Evidence. Synergies between the private/public sectors are increasingly popular in light of technology connectivity and increased transparency standards. Rarely do these objectives align as closely as this year’s partnership between Doctor Evidence LLC and the Guidelines International Network (G-I-N). Doctor Evidence will serve as the platinum sponsor of the G-I-N annual conference (August 20-23, 2014 in Melbourne, Australia) focused on how to use digital innovations to support ...